A comprehensive view of neurological/cognitive health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Neurogene announces FDA clearance of IND for NGN-401 gene therapy for children with Rett syndrome; Rett syndrome is an X-linked, progressive, neurodevelopmental disorder that affects 1 in 10,000 live female births

Eli Lilly reports FDA has rejected accelerated approval for its donanemab Alzheimer’s drug due to insufficient data from patients who used the drug for a year; donanemab removes amyloid protein plaques from the brains of people with early Alzheimer's

Reunion Neuroscience appoints Robert Alexander, M.D. as Chief Medical Officer; Dr. Alexander previously served as VP and Head of Clinical Science in the Neuroscience Therapeutic Area Unit at Takeda Pharmaceuticals

Mintel: In 2023, consumers to seek food/drink that helps with cognitive capacity, managing stress, optimizing brain function; other trends include experiential eating, meat substitutes, food for weather-related disasters, female health food, upcycled food

FDA grants accelerated approval to Biogen and Eisai's anti-amyloid beta protofibril antibody candidate Leqembi lecanemab to treat early Alzheimer's disease; Eisai has set wholesale acquisition cost for the drug at US$26,500 per year

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count